Artificial intelligence (AI) software developer MaxQ AI has appointed Tom Neufelder as its new chief technology officer (CTO).
Neufelder comes to the company with more than 30 years of experience leading global product development for several medical imaging companies, according to MaxQ AI. Most recently, he served as senior vice president, innovation leader of Philips Healthcare's diagnostic imaging business unit. He also had a stint at Philips as vice president of research and development for CT and advanced molecular imaging.
Prior to Neufelder's tenure at Philips, he also held various senior posts at GE Healthcare, including vice president of research and development at the vendor's outpatient electronic medical record department and director of engineering for GE's invasive cardiology unit, MaxQ AI said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
